Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

2,764 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,764 results

Testing effectiveness (Phase 2)Looking for participantsNCT04329065
What this trial is testing

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
University of Washington 25
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Weijia Fang, MD 43
Post-approval studies (Phase 4)Study completedNCT00645151
What this trial is testing

The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Testing effectiveness (Phase 2)Active Not RecruitingNCT06303167
What this trial is testing

Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 19
Not applicableStudy completedNCT04131504
What this trial is testing

Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)

Who this might be right for
Crohn's DiseaseIBD
Children's Hospital Medical Center, Cincinnati 239
Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Early research (Phase 1)Ended earlyNCT00093704
What this trial is testing

Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma

Who this might be right for
LymphomaLymphoproliferative Disorder
Jonsson Comprehensive Cancer Center 1
Not applicableLooking for participantsNCT04484064
What this trial is testing

Optimization of the Targeted Anticancer Therapies

Who this might be right for
Cancer
Centre Hospitalier Universitaire Vaudois 500
Not applicableStudy completedNCT05933109
What this trial is testing

Mental Imagery and Targeted Memory Reactivation in PTSD

Who this might be right for
Nightmares, REM-Sleep TypePTSD
University Hospital, Geneva 46
Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Not applicableWithdrawnNCT03244852
What this trial is testing

Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

Who this might be right for
Obsessive-Compulsive Disorder
Massachusetts General Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07510828
What this trial is testing

PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Beijing Biotech 60
Not applicableActive Not RecruitingNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Not applicableLooking for participantsNCT06135909
What this trial is testing

CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy

Who this might be right for
Pulmonary Hypertension
Chinese Pulmonary Vascular Disease Research Group 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Not applicableUnknownNCT05221632
What this trial is testing

Accelerated Continue Theta-burst Stimulation (acTBS)Treatment for Obsessive Compulsive Disease

Who this might be right for
Obsessive-Compulsive DisorderAccelerated Continue Theta-burst StimulationTranscranial Magnetic Stimulation+1 more
Anhui Medical University 60
Testing effectiveness (Phase 2)WithdrawnNCT01290406
What this trial is testing

BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT07263906
What this trial is testing

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

Who this might be right for
Refractory Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia
Second Affiliated Hospital, School of Medicine, Zhejiang University 48
Not applicableStudy completedNCT02132845
What this trial is testing

Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer

Who this might be right for
Malignant Neoplasm
Fox Chase Cancer Center 30
Early research (Phase 1)Looking for participantsNCT06469281
What this trial is testing

Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Regeneron Pharmaceuticals 90
Load More Results